Drug Discovery

InPro 8000 Series Turbidity Sensor

This fiber optic measuring system is based on the backscattered light principle and consequently provides the highest possible performance from low/medium turbidities right through to high suspended particle concentrations.

Kite, HiFiBiO Therapeutics partner to discover novel targets and antibodies against AML

Kite, a Gilead Company and HiFiBiO Therapeutics announced the companies have entered into a two-year research collaboration and license agreement in acute myeloid leukemia (AML).

Gilead, Jounce Therapeutics sign $805m worth licensing deal for JTX-1811

Gilead Sciences has signed an exclusive licensing deal worth up to $805m with Jounce Therapeutics for the latter's immunotherapy candidate JTX-1811.

Ionis to purchase 24% stake in Akcea Therapeutics for $500m

Ionis Pharmaceuticals has signed an agreement to purchase remaining stake in US-based biopharmaceutical company Akcea Therapeutics in a deal valued at around $500m.

BeiGene, Singlomics sign licencing agreement on neutralising Covid-19 antibodies

BeiGene has entered into an exclusive licence agreement with Singlomics (Beijing DanXu) Biopharmaceuticals for neutralising Covid-19 antibodies.

Engitix signs collaboration and licensing agreement with Takeda to develop anti-fibrotic therapies in advanced liver diseases

Engitix, a biotechnology company developing a portfolio of programmes in fibrosis and solid tumours using its proprietary human extracellular matrix (ECM) platform, today entered into a licensing and collaboration agreement with Takeda Pharmaceutical Company to discover and develop novel therapeutics for advanced fibrotic liver diseases, including non-alcoholic steatohepatitis (NASH).

Sinovac signs agreement with Bio Farma Indonesia for Covid-19 vaccine cooperation

Sinovac Biotech, a leading provider of biopharmaceutical products in China, today announced it has signed two agreements in Hainan, China with PT Bio Farma, a leading biopharmaceutical company in Indonesia, for the supply, local production and technology licensing in respect of the CoronaVac, Sinovac’s inactivated vaccine candidate against Covid-19.

Acadia buys clinical-stage biotechnology company CerSci Therapeutics

Acadia Pharmaceuticals has added novel pain programme to its portfolio with the acquisition of clinical-stage biotechnology company CerSci Therapeutics.

Bristol Myers Squibb to buy clinical-stage protein engineering firm Forbius

Bristol Myers Squibb (BMS) has signed an agreement to acquire clinical-stage protein engineering company Forbius for an undisclosed sum.